Abeona Therapeutics Inc. diskutieren
Abeona Therapeutics Inc.
WKN: A3DMHM / Symbol: ABEO / Name: Abeona Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
5,45 €
-0,91 %
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $36.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its price target lowered by analysts at Cantor Fitzgerald from $28.00 to $21.00. They now have an "overweight" rating on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $18.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $18.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $16.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its price target raised by analysts at HC Wainwright from $15.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) had its price target lowered by analysts at Stifel Nicolaus from $21.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc (NASDAQ: ABEO) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $19.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc. (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Camtek Ltd. diskutieren